# Vascular contribution to cognitive impairment and dementia (VCID): proceedings of 2025 workshop of the Jackson Laboratory

**Authors:** Mehwish Anwer, Tetiana Poliakova, Ricardo D’Oliveira Albanus, Mohammad Iqbal H. Bhuiyan, Adam M. Brickman, Soumilee Chaudhuri, Leah Cuddy, Maxwell Eisenbaum, Kate Foley, Douglas B. Gould, Catherine Hall, Costantino Iadecola, Olivia Marola, Christopher M. Norris, Alaina Reagan, Julie Schneider, Donna Wilcock, Isabella Xu, Andrew Yang, Gareth Howell, Cheryl L. Wellington

PMC · DOI: 10.1007/s00335-026-10210-x · Mammalian Genome · 2026-03-14

## TL;DR

A workshop on vascular contributions to dementia was held to foster collaboration and train new scientists in understanding and treating dementia.

## Contribution

The workshop emphasized interdisciplinary collaboration and training to advance VCID and ADRD research through experimental models.

## Key findings

- The workshop highlighted the role of neurovascular pathology in ADRD pathogenesis.
- It emphasized the need to dissect VCID mechanisms through experimental models.
- Keynote addresses by leading experts aimed to inspire and guide future research.

## Abstract

The first Vascular Contributions to Cognitive Impairment and Dementia (VCID) Workshop, held on May12-16, 2025 at The Jackson Laboratory, provided scientific content and career development training in the latest developments in VCID and Alzheimer’s Disease (AD) and related dementia (ADRD). The Workshop aimed to foster interdisciplinary collaborations and empower the next generation of diverse scientists to advance ADRD research from mechanism to intervention. The meeting placed a strong emphasis on neurovascular pathology, its central role in ADRD pathogenesis, its modulation by both central and peripheral factors, and the critical need to dissect the mechanistic basis of VCID through experimental models. The workshop included talks from both faculty and trainees and was bookended by two keynote addresses by Drs. Donna Wilcock and Costantino Iadecola, leaders and pioneers in the VCID field. The second VCID workshop is planned for April 28-May 1, 2026, to be held at Washington University in St. Louis.

## Linked entities

- **Diseases:** Alzheimer’s Disease (MONDO:0004975), dementia (MONDO:0001627)

## Full-text entities

- **Genes:** Trex1 (three prime repair exonuclease 1) [NCBI Gene 22040], Cybb (cytochrome b-245, beta polypeptide) [NCBI Gene 13058] {aka CGD91-phox, Cgd, Cyd, Nox2, gp91-1, gp91phox}, Hpx (hemopexin) [NCBI Gene 15458] {aka Hpxn, hx}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, Lrp1 (low density lipoprotein receptor-related protein 1) [NCBI Gene 16971] {aka A2mr, CD91, Lrp, b2b1554Clo}, Foxc1 (forkhead box C1) [NCBI Gene 17300] {aka FREAC3, Fkh1, Mf1, Mf4, ch, fkh-1}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, Mthfr (methylenetetrahydrofolate reductase) [NCBI Gene 17769], Kcnj6 (potassium inwardly-rectifying channel, subfamily J, member 6) [NCBI Gene 16522] {aka BIR1, GIRK2, KATP2, KCNJ7, Kir3.2, weaver}, Trpm2 (transient receptor potential cation channel, subfamily M, member 2) [NCBI Gene 28240] {aka 9830168K16Rik, LTRPC2, TRPC7, Trp7, Trrp7}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Hp (haptoglobin) [NCBI Gene 15439] {aka HP-1, preHP2}, Agt (angiotensinogen) [NCBI Gene 11606] {aka AngI, AngII, Aogen, Serpina8}, Ctsd (cathepsin D) [NCBI Gene 13033] {aka CD, CatD}, Scarb1 (scavenger receptor class B, member 1) [NCBI Gene 20778] {aka CD36, Cd36l1, Chohd1, Cla-1, Cla1, D5Ertd460e}, Notch3 (notch 3) [NCBI Gene 18131] {aka N3, hpbk}, Gc (vitamin D binding protein) [NCBI Gene 14473] {aka DBP, VDB}, Il17ra (interleukin 17 receptor A) [NCBI Gene 16172] {aka Cdw217, Il17r, VDw217}, CETP (cholesteryl ester transfer protein) [NCBI Gene 1071] {aka BPIFF, HDLCQ10}, Cav1 (caveolin 1, caveolae protein) [NCBI Gene 12389] {aka Cav, Cav-1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, Htra1 (HtrA serine peptidase 1) [NCBI Gene 56213] {aka HTRA, L56, Prss11, RSPP11}, Col4a2 (collagen, type IV, alpha 2) [NCBI Gene 12827] {aka Col4a-2}, Agtrap (angiotensin II, type I receptor-associated protein) [NCBI Gene 11610] {aka 3300002E14Rik, AT1R, Atrap, D4Wsu124e}, Apoa1 (apolipoprotein A-I) [NCBI Gene 11806] {aka Alp-1, Apoa-1, Brp-14, Ltw-1, Lvtw-1, Sep-1}, Tspo (translocator protein) [NCBI Gene 12257] {aka Bzrp, IBP, PBR, Tspo1}, Nos3 (nitric oxide synthase 3, endothelial cell) [NCBI Gene 18127] {aka 2310065A03Rik, Nos-3, eNOS, ecNOS}, Ahsg (alpha-2-HS-glycoprotein) [NCBI Gene 11625], Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Stk39 (serine/threonine kinase 39) [NCBI Gene 53416] {aka DCHT, Gm50618, RF005, Rnl5, SPAK}, Slc12a2 (solute carrier family 12, member 2) [NCBI Gene 20496] {aka 9330166H04Rik, BSC2, Nkcc1, mBSC2, mNKCC1, sy-ns}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, Trf (transferrin) [NCBI Gene 22041] {aka Cd176, HP, Tf, Tfn, hpx}, Ighv1-62 (immunoglobulin heavy variable 1-62) [NCBI Gene 668542] {aka IgG, IgM, IgVH, Igh}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Nefl (neurofilament, light polypeptide) [NCBI Gene 18039] {aka CMT2E, NF-L, NF68, Nfl}, Angpt2 (angiopoietin 2) [NCBI Gene 11601] {aka Agpt2, Ang-2, Ang2}, Col4a1 (collagen, type IV, alpha 1) [NCBI Gene 12826] {aka Bru, Col4a-1, Raw, Svc}, Dbp (D site albumin promoter binding protein) [NCBI Gene 13170], Clic4 (chloride intracellular channel 4) [NCBI Gene 29876] {aka D0Jmb3, TU-74, mc3s5, mtCLIC}, Aif1 (allograft inflammatory factor 1) [NCBI Gene 11629] {aka AIF-1, D17H6S50E, G1, Iba1}, Stk24 (serine/threonine kinase 24) [NCBI Gene 223255] {aka 1810013H02Rik, MST-3, Mst3, STE20}, Pgf (placental growth factor) [NCBI Gene 18654] {aka PIGF, Plgf}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 83433] {aka TREM-2, Trem2a, Trem2b, Trem2c}
- **Diseases:** coronary heart disease (MESH:D003327), BAM (MESH:D001882), cerebral atherosclerosis (MESH:D002537), vascular brain injury (MESH:D020214), extracellular (MESH:C535509), astrogliosis (MESH:D005911), pathology (MESH:D005598), hypoxia (MESH:D000860), proteinopathies (MESH:D057165), cerebral hypometabolism (MESH:D002547), brain (MESH:D001927), Neurovascular dysfunction (MESH:D013901), ocular (MESH:D015817), energy metabolism (MESH:D008659), ADRD (MESH:D003704), ischemic (MESH:D002545), cerebrovascular disease (MESH:D002561), amyloid plaques (MESH:D058225), Vascular disease (MESH:D014652), Down syndrome (MESH:D004314), inflammation (MESH:D007249), BBB (MESH:C536830), neuronal loss (MESH:D009410), head injury (MESH:D006259), impaired spatial learning and memory (MESH:D008569), CAA (MESH:D016657), TBI (MESH:D000070642), Vascular dementia (MESH:D015140), AD (MESH:D000544), carotid artery stenosis (MESH:D016893), metabolic syndrome (MESH:D024821), brain damage (MESH:D001925), Neurological Disorders (MESH:D009461), amyloid (MESH:C000718787), hypoxic (MESH:D002534), Hypertension (MESH:D006973), hypertrophy (MESH:D006984), Lewy bodies (MESH:D020961), collagen IV-related disease (MESH:D003095), death (MESH:D003643), demyelination (MESH:D003711), vascular damage (MESH:D057772), arteriolosclerosis (MESH:D050379), infarcts (MESH:D007238), learning and memory deficits (MESH:D007859), intracerebral hemorrhages (MESH:D002543), anterior segment dysgenesis (MESH:C537775), PADMAL (MESH:C531642), arteriosclerosis (MESH:D001161), gliovascular dysfunction (MESH:D006331), WMH (MESH:D056784), injury (MESH:D014947), transient ischemic attack (MESH:D002546), MCI (MESH:D060825), NFTs (MESH:D055956), hemorrhagic (MESH:D006470), axonal damage (MESH:D001480), brain infarcts (MESH:D020520), Stroke (MESH:D020521), hemorrhagic strokes (MESH:D000083302)
- **Chemicals:** salt (MESH:D012492), 4PBA (MESH:C075773), folate (MESH:D005492), reactive oxygen species (MESH:D017382), -phenylbutyrate (MESH:D010654), sodium (MESH:D012964), vitamin D (MESH:D014807), losartan (MESH:D019808), clodronate (MESH:D004002), methionine (MESH:D008715), Oxygen (MESH:D010100), cholesterol (MESH:D002784), BAM (-), calcium (MESH:D002118), captopril (MESH:D002216), lipid (MESH:D008055), DOCA (MESH:D064791), iron (MESH:D007501)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** 677C > T, R1279Q, R1284Q, CAA at 14
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12988892/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12988892/full.md

---
Source: https://tomesphere.com/paper/PMC12988892